Newer weight-reduction surgery effective, but may worsen acid reflux
(Reuters Health) - The two most popular types of weight-reduction surgery are almost equally effective at shedding pounds, reversing diabetes and possibly improving survival.
In this study, 414 Emirati patients with RA were evaluated over a 3-year period from April 2015 to April 2018. All patients fulfilled the 2010 RA ACR/EULAR criteria and were assessed for demographic and clinical characteristics. The estimated RA prevalence rate in our population cohort was 2.72%. Females showed predominance (80%) with a higher body mass index (31.4 ± 6.61, P = 0.0001) compared to males (28.8 ± 6.03, P = 0.0001). The most frequent comorbidity observed was dyslipidemia (43.5%) followed by hypertension (37.9%), diabetes mellitus (34.5%), and gastroesophageal reflux di...
CONCLUSIONS: The paper demonstrates that the autonomic dysfunction of nervous system (on a par with insulin resistance) is the main link in the development of MetS. This provides the basis for including the mentioned states - cardiac autonomic neuropathy, lower urinary tract symptoms and gastroesophageal reflux disease - into the MetS cluster. PMID: 31589129 [PubMed - as supplied by publisher]
To compare the effects of sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) on gastroesophageal reflux disease (GERD) one year after surgery.
54 years old female from Calgary Alberta Canada who had a Vertical Banded Gastroplasty (VBG) in 2002 in Canada; in 2011 she requested me a revision from VBG to a gastric band due to weight regain with modest results and ultimately regaining all her weight back and developing gastro-esophageal reflux, GERD) she came back for a second revision in 2018 requesting a laparoscopic sleeve gastrectomy (LSG). Her initial BMI was 42 with two major co-morbidities diabetes mellitus (DMII) and high blood pressure (HBP)that went under remission with the primary surgery ; but due to de novo GERD and weight regain due to a band revision s...
CONCLUSIONS: Although GORD is common in subjects with ACS, we have not been able to show that GORD may serve as a trigger for ischaemia in these subjects. PMID: 31591635 [PubMed - as supplied by publisher]
Publication date: October 2019Source: Canadian Journal of Diabetes, Volume 43, Issue 7, SupplementAuthor(s): James M. Bowen, Robert B. Hopkins, LIFENG Xie, Gord Blackhouse, Daria J. O’reilly
This report highlights the occurrence of this rare and benign cause of dysphagia in Nigeria. Funding: None declared. PMID: 31481816 [PubMed - in process]
This study investigated the therapeutic outcomes of LDJB-SG and predictors of type 2 diabetes (T2D) remission in Chinese patients with a body mass index (BMI) of 20 to 32.5 kg/m2. SETTING: A university hospital. METHODS: This retrospective study included 28 T2D patients with a BMI of 20 to 32.5 kg/m2 who underwent LDJB-SG. T2DM remission, weight loss, postoperative nutrition status, and complications at 1- and 3-year follow-up were assessed. Remission of T2DM was defined as a fasting blood glucose
An 82-year-old male, with a history of bowel cancer with partial colectomy, gastroesophageal reflux disease, remote partial gastrectomy for peptic ulcer disease, and no documented prior kidney disease, presents with several months of fatigue and subacute decline in kidney function. He had no history of diabetes, hypertension, kidney stones, or prior urinary tract infections. He denied use of nonsteroidal anti-inflammatory agents, herbal medications, and recent antibiotics. There was no family history of renal disease.
Conclusions: A considerable proportion of NCD patients with easily detectable attributes are at risk of developing OSA, but still remain undiagnosed at a primary health care setting. The results obtained using MBQ in this study were comparable to studies performed using polysomnography. Dyslipidemia, body mass index and waist circumference were independent risk factors for predicting a risk of developing OSA. Prospective studies are needed to confirm whether a reduction in these risk factors could reduce the risk for OSA. PMID: 31330779 [PubMed - in process]